All News
RheumNow’s expanded coverage of #ACR24 is sponsored in part by Novartis. All content is chosen by RheumNow & its faculty.
Dr. John Cush RheumNow ( View Tweet)
@kekuchinad A#1689 PFT ref equations -> inequities in SSc ILD Predict FVC uses age, ht, sex & race - higher % pred values -> underdx Race-specific v neutral equations: More black pts meet trial eligibility (69/57%), immunos (56/40), lung t, (14/9) @RheumNow #ACR24 #ACRBest https://t.co/40PFmdk3Xv
Links:
Eric Dein ericdeinmd ( View Tweet)
Very neat simulated model of GC regimens in AAV pt on fixed RTX by @zach_wallace_md and co
Over 5 years:
- No difference in relapse btwn standard GC vs. minimal GC + avacopan
- Higher DMII rates in standard group
Adds to trial + real world data
@RheumNow #ACR24 Abst 1598
Brian Jaros, MD Dr_Brian_MD ( View Tweet)
Will my patient with lupus nephritis respond well to induction therapy?
Abstract 1685: Aundhia et al demonstrate the promising utility of RAIL to predict complete renal response in patients with lupus nephritis (Class III or IV +/- V)
@RheumNow #ACR24 https://t.co/JBldrrwUhN
Akhil Sood MD AkhilSoodMD ( View Tweet)
Belimumab, anifrolumab and voclosporin exhibited an increase in claims from 2017-2022 for #SLE
Belimumab ~ 600% increase!!
@RheumNow #ACR24 abst#1259 https://t.co/norl1xk2KF
Bella Mehta bella_mehta ( View Tweet)
Smoking and Rx progression in PsA?
-Prospective Canadian cohort of 1736 PsA pts.
-Older age, BL SJC, dactylitis, erosions and high ESR were associated with Rx progression.
🚨Cigarette smoking did not appear to be associated with the Rx progression in PsA.
Abst#1436 #ACR24… https://t.co/J2IogqOlx8 https://t.co/U6SRmbOE6o
Links:
Adela Castro AdelaCastro222 ( View Tweet)
Petri: 5 mg prednisone or less is our standard for lupus control
EULAR 23 recs - early addition of immunosuppressant and/or biologics instead to prevent steroids
@RheumNow
#ACR24 @jhrheumatology https://t.co/jhxEeboPu5
Links:
Eric Dein ericdeinmd ( View Tweet)
RheumNow’s expanded coverage of the #ACR24 meeting is sponsored in part by Bristol Myers Squibb and UCB. All content is chosen by RheumNow & its faculty
Dr. John Cush RheumNow ( View Tweet)
John Stone
Steroid-free AAV
CYCLOPS: steroid tox like “wallpaper on room”
WGET (ETN for GCA) - taper off by 6 mos - neg trial but started tapers
RAVE - low doses 8-9 mg/d over 18 mos
LoVAS - low dose steroid equally eff
ADVOCATE - AVA one month taper, tox score
#ACR24 @RheumNow https://t.co/C7eLK5UNPM
Links:
Eric Dein ericdeinmd ( View Tweet)
Biosimilar changes
ASP outpacing reimbursement making not affordable to use
Working with CMS but needs further legislation to fix this
FDA may change interchangeability status for medications to no longer require switching studies
@ACRheumDC @RheumNow #ACR24 https://t.co/daYQJvsHRG
Links:
Eric Dein ericdeinmd ( View Tweet)
What’s on tap for Trump health care agenda?
Uncertainty as to what priorities and actions will be
ACR has plans to address legislative, regulatory, and state affairs
@ACRheumDC #ACR24 @RheumNow https://t.co/a5z4RIOjRC
Eric Dein ericdeinmd ( View Tweet)
@ACRheumDC State Update:
No changes at executive level
Some shifts in state legislation
With political changes and new administration, states will probably take larger role in healthcare legislation
- PBM reform, copay accum, prior auth/step, reprod healthcare
@RheumNow #ACR24 https://t.co/jc77HCLxqQ
Links:
Eric Dein ericdeinmd ( View Tweet)
State Update @ACRheumDC
No executive level changes, some state legislative flips
Political changes will likely lead to more state legislative healthcare legislation
- In the works for PBM reform, copay accum, prior auth/Step, reprod healthcare
@RheumNow #ACR24 https://t.co/94KyHU0Blr
Links:
Eric Dein ericdeinmd ( View Tweet)
Regulatory update @ACRheumDC
Inflation Reduction
Planned decrease in 10 drug prices including ETN
Expect this may be gutted by new administration. Will follow and advocate for drug pricing
@RheumNow #ACR24 https://t.co/ZrcMaLD6tu
Links:
Eric Dein ericdeinmd ( View Tweet)
119 Congress - prepare for change
Obamacare subsidies set to expire
NIH changes and possible reorg
ACR champions are in gov positions for both parties
Focus on affecting change that is practical, possible and improves rheumatology practice
@ACRheumDC @LennMcD
@RheumNow #ACR24 https://t.co/tcxixdlSWQ
Links:
Eric Dein ericdeinmd ( View Tweet)
@LennMcD @ACRheumDC
Do policies affect medication access, costs, reimbursements, telehealth, or your life as a rheumatology provider or patients?
Contact - quick and easy!
https://t.co/TvMlXiIZQR
@RheumNow #ACR24 https://t.co/plnUtl7Kml https://t.co/lFGx7hzlKy
Links:
Eric Dein ericdeinmd ( View Tweet)
@ACRheumDC
Check out the ACR policy position statements
Created by volunteer-led, non-partisan group of GAC committee - changes based on the needs of the ACR members
@cdowneymd
https://t.co/oAFfYUct4y
@RheumNow #ACR24 https://t.co/MmVd8XYs0j
Links:
Eric Dein ericdeinmd ( View Tweet)
If you are not at the table, you are on the menu
https://t.co/c4anIn3aue
@cdowneymd @ACRheumDC
Join a committee
RheumPAC
Write a letter
Write a post card at ACR Hub at #ACR24
Advocacy office hours with ACR staff
#Act4Arthritis & Advocacy 101 on Cap Hill
@RheumNow https://t.co/bpilydxEpB
Links:
Eric Dein ericdeinmd ( View Tweet)
@LennMcD @ACRheumDC
Current congress (118th) - very tight margins, paralyzed by the ‘24 elections. Now in lame duck
Many ACR policies made into bills - PA, step rx, copay accumulator, workforce, loan repayment, incr Rx transparency
Needs to be passed into law
@RheumNow #ACR24 https://t.co/1elEUiUAmh
Eric Dein ericdeinmd ( View Tweet)
@LennMcD
@ACRheumDC
Many ACR priorities in bills, needs to be passed in law
Victories:
Incr NIH biomedical research funding, added to DoD funds
Medicare reimbursem and telehealth needs addressed by lame duck congress
Get involved, reach out, write letters
@RheumNow #ACR24 https://t.co/7oCvUFWpx4
Links:
Eric Dein ericdeinmd ( View Tweet)
